Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slack

Showing results (71-80 of 472) with videos related to

Pageof 48
Sort By:
Expert Opinion on Drug Discovery|May 19, 2020
Challenges identifying efficacious miRNA therapeutics for cancerMeirav Segal, Frank J Slack
The New England Journal of Medicine|December 19, 2008
MicroRNA in cancer prognosisFrank J Slack, Joanne B Weidhaas
Current Opinion in Molecular Therapeutics|April 8, 2010
Potential microRNA therapies targeting Ras, NFkappaB and p53 signalingAndrea L Kasinski, Frank J Slack
Cell Cycle (Georgetown, Tex.)|August 23, 2008
microRNAs and cancer: an overviewPedro P Medina, Frank J Slack
Cancer Journal (Sudbury, Mass.)|June 1, 2012
The duality of oncomiR addiction in the maintenance and treatment of cancerChristopher J Cheng, Frank J Slack
British Journal of Pharmacology|February 17, 2012
Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4R J Slack, D A Hall
Molecular Therapy. Nucleic Acids|January 25, 2013
Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCCAndrea L Kasinski, Frank J Slack
Bio-Protocol|May 31, 2016
Generation of Mouse Lung Epithelial CellsAndrea L Kasinski, Frank J Slack
Journal of Cancer Metastasis and Treatment|July 2, 2021
Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancerChristos N Miliotis, Frank J Slack
Cell|November 16, 2019
The Role of Non-coding RNAs in OncologyFrank J Slack, Arul M Chinnaiyan
Pageof 48

Showing results (71-80 of 472) with videos related to

Sort By:
Pageof 48
Expert Opinion on Drug Discovery|May 19, 2020
Challenges identifying efficacious miRNA therapeutics for cancerMeirav Segal, Frank J Slack
The New England Journal of Medicine|December 19, 2008
MicroRNA in cancer prognosisFrank J Slack, Joanne B Weidhaas
Current Opinion in Molecular Therapeutics|April 8, 2010
Potential microRNA therapies targeting Ras, NFkappaB and p53 signalingAndrea L Kasinski, Frank J Slack
Cell Cycle (Georgetown, Tex.)|August 23, 2008
microRNAs and cancer: an overviewPedro P Medina, Frank J Slack
Cancer Journal (Sudbury, Mass.)|June 1, 2012
The duality of oncomiR addiction in the maintenance and treatment of cancerChristopher J Cheng, Frank J Slack
British Journal of Pharmacology|February 17, 2012
Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4R J Slack, D A Hall
Molecular Therapy. Nucleic Acids|January 25, 2013
Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCCAndrea L Kasinski, Frank J Slack
Bio-Protocol|May 31, 2016
Generation of Mouse Lung Epithelial CellsAndrea L Kasinski, Frank J Slack
Journal of Cancer Metastasis and Treatment|July 2, 2021
Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancerChristos N Miliotis, Frank J Slack
Cell|November 16, 2019
The Role of Non-coding RNAs in OncologyFrank J Slack, Arul M Chinnaiyan
Pageof 48